Bevacizumab or laser for aggressive posterior retinopathy of prematurity

PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Taiwan J Ophthalmol
Main Authors: Blair, Michael, Gonzalez, Jose Maria Garcia, Snyder, Laura, Schechet, Sidney, Greenwald, Mark, Shapiro, Michael, Rodriguez, Sarah Hilkert
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications & Media Pvt Ltd 2018
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302568/
https://ncbi.nlm.nih.gov/pubmed/30637196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_69_18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki